» Articles » PMID: 29533679

Chronic Obstructive Pulmonary Disease As a Risk Factor for Cardiovascular Disease. A View from the SUMMIT

Overview
Specialty Critical Care
Date 2018 Mar 14
PMID 29533679
Citations 8
Authors
Affiliations
Soon will be listed here.
Citing Articles

Temporal Dynamics of Cardiovascular Risk in Patients with Chronic Obstructive Pulmonary Disease During Stable Disease and Exacerbations: Review of the Mechanisms and Implications.

Simons S, Heptinstall A, Marjenberg Z, Marshall J, Mullerova H, Rogliani P Int J Chron Obstruct Pulmon Dis. 2024; 19:2259-2271.

PMID: 39411574 PMC: 11474009. DOI: 10.2147/COPD.S466280.


Risk of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: results from the EXACOS-CV cohort study using the PHARMO Data Network in the Netherlands.

Swart K, Baak B, Lemmens L, Penning-van Beest F, Bengtsson C, Lobier M Respir Res. 2023; 24(1):293.

PMID: 37990197 PMC: 10662240. DOI: 10.1186/s12931-023-02601-4.


EXAcerbations of COPD and their OutcomeS on CardioVascular diseases (EXACOS-CV) Programme: protocol of multicountry observational cohort studies.

Nordon C, Rhodes K, Quint J, Vogelmeier C, Simons S, Hawkins N BMJ Open. 2023; 13(4):e070022.

PMID: 37185641 PMC: 10151875. DOI: 10.1136/bmjopen-2022-070022.


A Nomogram for Predicting Cardiovascular Diseases in Chronic Obstructive Pulmonary Disease Patients.

Qu S, Zhu J J Healthc Eng. 2022; 2022:6394290.

PMID: 36304748 PMC: 9596246. DOI: 10.1155/2022/6394290.


Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary disease.

Li N, Dai Z, Wang Z, Deng Z, Zhang J, Pu J Respir Res. 2021; 22(1):274.

PMID: 34696775 PMC: 8543848. DOI: 10.1186/s12931-021-01872-z.